Phase 3 Irritable Bowel Syndrome Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be 18 years of age or older
- Both men and women can participate, but women must have a negative pregnancy test and be using effective contraception
- You must have been diagnosed with Irritable Bowel Syndrome (IBS) according to a standard set of medical guidelines called the Rome IV criteria
- Your average pain level over the 7 days before joining must be rated at least 4 out of 10 on a pain scale
- Any current IBS treatments you are taking must have stayed the same for at least 1 month before joining
Who may not be able to join:
- You are currently breastfeeding
- You have diabetes
- You have significant liver problems or moderate kidney disease (confirm with trial site)
- You have an addiction to alcohol or drugs
- You are taking anti-epilepsy medications for epilepsy or long-term pain
- You have another chronic pain condition that is more severe than your IBS pain
- You have a known allergy to certain medications called succinimides (such as ethosuximide, methsuximide, or phensuximide) or to pentoxifylline
- You have a history of, or currently have, severe depression that required hospital treatment or long-term use of antidepressants
- You have or have had a psychotic disorder
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mostafa Mahmoud Bahaa El dien, Msc, Clinical Pharmacy department
Phone: 00201147773440
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of patients with improved Visual analog scales (VAS) for assessment of pain in IBS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.